China-Biotics (CHBT) Stock Price, News & Analysis

Company Overview

China-Biotics, Inc. is a biopharmaceutical company focused on the development and commercialization of natural compounds derived from traditional Chinese medicinal plants. The company’s core activities center on the isolation, characterization and formulation of bioactive ingredients that exhibit anti-viral, anti-bacterial and immune-modulating properties. By leveraging proprietary extraction processes and analytical methodologies, China-Biotics seeks to advance novel botanical drug candidates from discovery through early-stage development.

The company’s research pipeline includes a range of botanical derivatives under preclinical evaluation for applications in respiratory infections, immune support and related therapeutic areas. In addition to its pharmaceutical development efforts, China-Biotics explores nutraceutical and dietary supplement formulations designed to deliver standardized herbal extracts to global consumer markets. Its product concepts draw upon scientifically documented traditional remedies, with an emphasis on safety, consistency and regulatory compliance.

Headquartered in the United States with research collaborations and manufacturing partnerships in China, China-Biotics combines access to rich herbal resources with Western regulatory expertise. The firm works closely with contract research organizations, academic laboratories and contract manufacturers to advance its botanical programs through proof-of-concept studies, formulation optimization and quality-assurance testing.

Led by a management team with experience in pharmaceutical R&D, herbal medicine development and global supply-chain management, China-Biotics aims to bridge the gap between traditional remedies and modern drug discovery. The company’s strategic focus on natural bioactive molecules positions it to address unmet needs in anti-infective therapies and supportive care products.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CHBT Stock Analysis - Frequently Asked Questions

How do I buy shares of China-Biotics?

Shares of CHBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of China-Biotics own?

Based on aggregate information from My MarketBeat watchlists, some other companies that China-Biotics investors own include Arcimoto (FUV), First Solar (FSLR), Ethan Allen Interiors (ETH), eBay (EBAY), Cisco Systems (CSCO), ChargePoint (CHPT) and Canopy Growth (CGC).

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Basic Materials
• Industry: Mining And Quarrying Nonmetallic Minerals
• Sub-Industry: Non-Metallic And Industrial Metal Mining
• Current Symbol: OTCMKTS:CHBT
• CIK: 1271057
• Web: N/A
• Phone: +86-21-58349748
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A